Drug intelligence / Profile preview

green tea constituents

Development stage
Unknown
Lead developer
Rutgers University
Modality
Small Molecules
Administration
Topical
01

Overview

This investigational topical treatment, developed by Rutgers, The State University of New Jersey, utilizes specific constituents derived from green tea (*Camellia sinensis*), namely caffeine and (-)-epigallocatechin gallate (EGCG), to protect against ultraviolet (UV)-induced skin damage and sunburn. The treatment is applied topically to the skin following UV exposure. Its mechanism of action involves enhancing the expression of the p53 protein and activating caspase-3, which collectively promote apoptosis (programmed cell death) in DNA-damaged skin cells. By facilitating the removal of these damaged cells, the treatment aims to reduce the risk of UV-induced erythema and long-term skin damage. It has been evaluated in Phase 2 clinical trials as a topical solution applied immediately and at sequential time points after UVB exposure.

Other names
caffeine(-)-epigallocatechin gallateEGCGgreen tea-Rutgers, The State University of New Jersey-sunburntopical green tea constituents
02

Targets

HDAC (HDAC family)TP53 (Cellular Tumor Antigen p53 R175H)

Beyond the preview

Go deeper on green tea constituents.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on green tea constituents.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call